Cerecor acquires TRx for $23M

Neurology play Cerecor Inc. (NASDAQ:CERC) acquired therapeutic company TRx Pharmaceuticals LLC for $23 million, comprising $18.9 million in cash and $4.1 million in stock. Cerecor also acquired TRx's pediatric supplement subsidiary Zylera Pharmaceuticals LLC for an additional $4 million in stock...